Chitosan-based nanomaterials for drug delivery
This review discusses different forms of nanomaterials generated from chitosan and its
derivatives for controlled drug delivery. Nanomaterials are drug carriers with multiple …
derivatives for controlled drug delivery. Nanomaterials are drug carriers with multiple …
Rational design of cancer nanomedicine for simultaneous stealth surface and enhanced cellular uptake
Q Jin, Y Deng, X Chen, J Ji - Acs Nano, 2019 - ACS Publications
Owing to the complex and still not fully understood physiological environment, the
development of traditional nanosized drug delivery systems is very challenging for precision …
development of traditional nanosized drug delivery systems is very challenging for precision …
Orally deliverable sequence-targeted astaxanthin nanoparticles for colitis alleviation
Y Chen, W Su, S Tie, W Cui, X Yu, L Zhang, Z Hua… - Biomaterials, 2023 - Elsevier
Orally targeted strategy of anti-inflammatory agents has attracted tremendous attention for
reducing highly health-care costs and enhancing the intervention efficiency of ulcerative …
reducing highly health-care costs and enhancing the intervention efficiency of ulcerative …
Current advances in multifunctional nanocarriers based on marine polysaccharides for colon delivery of food polyphenols
S Tie, M Tan - Journal of Agricultural and Food Chemistry, 2022 - ACS Publications
Inflammatory bowel disease (IBD) has been considered as a chronic disease that is difficult
to cure and needs lifelong treatment. Marine polysaccharides with good biocompatibility and …
to cure and needs lifelong treatment. Marine polysaccharides with good biocompatibility and …
[HTML][HTML] Charge-reversal nanomedicines as a smart bullet for deep tumor penetration
Complex composition and abnormal growth state of cells and tissues in the solid tumor
microenvironment often lead to high density and stiffness different from normal tissues, thus …
microenvironment often lead to high density and stiffness different from normal tissues, thus …
Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy
Y Liu, L Qiao, S Zhang, G Wan, B Chen, P Zhou… - Acta Biomaterialia, 2018 - Elsevier
In the present study, a dual pH-responsive multifunctional nanoparticle system was
designed for combining immunotherapy and chemotherapy to treat breast cancer through …
designed for combining immunotherapy and chemotherapy to treat breast cancer through …
Light-responsive nanoparticles for highly efficient cytoplasmic delivery of anticancer agents
Y Wang, Y Deng, H Luo, A Zhu, H Ke, H Yang… - ACS nano, 2017 - ACS Publications
Stimuli-responsive nanostructures have shown great promise for intracellular delivery of
anticancer compounds. A critical challenge remains in the exploration of stimuli-responsive …
anticancer compounds. A critical challenge remains in the exploration of stimuli-responsive …
Dual targeting procyanidin nanoparticles with glutathione response for colitis treatment
The purpose of this study is to design a cell membrane and mitochondrial targeting
nanoparticle with glutathione stimulus response to deliver procyanidin for effective treatment …
nanoparticle with glutathione stimulus response to deliver procyanidin for effective treatment …
Chitosan-based nanoparticles of targeted drug delivery system in breast cancer treatment
Breast cancer remains one of the world's most dangerous diseases because of the difficulty
of finding cost-effective and specific targets for effective and efficient treatment methods. The …
of finding cost-effective and specific targets for effective and efficient treatment methods. The …
[HTML][HTML] Co-delivery of VEGF siRNA and etoposide for enhanced anti-angiogenesis and anti-proliferation effect via multi-functional nanoparticles for orthotopic non …
F Li, Y Wang, W Chen, D Wang, Y Zhou, B You… - Theranostics, 2019 - ncbi.nlm.nih.gov
Targeting tumor angiogenesis pathway via VEGF siRNA (siVEGF) has shown great potential
in treating highly malignant and metastatic non-small cell lung cancer (NSCLC). However …
in treating highly malignant and metastatic non-small cell lung cancer (NSCLC). However …